 "Dr Lal PathLabs: Street worried over rising pressures")
Diagnostic services provider Dr Lal Path Labs on Thursday said its consolidated net profit declined 57 per cent to Rs 58 crore for the first quarter ended June 30.
The company had reported a net profit of Rs 134 crore in the April-June period of the last fiscal.
Revenue from operations declined to Rs 503 crore in the period under review from Rs 607 crore a year ago, Dr Lal PathLabs said in a regulatory filing.
The company's board has also declared an interim dividend of Rs 6 per share for the current fiscal.
Shares of the company were trading 1.27 per cent down at Rs 2,142.7 apiece on BSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
